These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27712130)

  • 1. Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.
    Steen NE; Aas M; Simonsen C; Dieset I; Tesli M; Nerhus M; Gardsjord E; Mørch R; Agartz I; Melle I; Ueland T; Spigset O; Andreassen OA
    World J Biol Psychiatry; 2017 Sep; 18(6):471-482. PubMed ID: 27712130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients.
    Torrent C; Martinez-Arán A; Daban C; Amann B; Balanzá-Martínez V; del Mar Bonnín C; Cruz N; Franco C; Tabarés-Seisdedos R; Vieta E
    Compr Psychiatry; 2011; 52(6):613-22. PubMed ID: 21295774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disparate effects of first and second generation antipsychotics on cognition in schizophrenia - Findings from the randomized NeSSy trial.
    Veselinović T; Scharpenberg M; Heinze M; Cordes J; Mühlbauer B; Juckel G; Habel U; Rüther E; Timm J; Gründer G;
    Eur Neuropsychopharmacol; 2019 Jun; 29(6):720-739. PubMed ID: 30981585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder.
    Kozicky JM; Torres IJ; Bond DJ; Lam RW; Yatham LN
    Int Clin Psychopharmacol; 2012 Mar; 27(2):91-9. PubMed ID: 22124206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.
    Fraguas D; Correll CU; Merchán-Naranjo J; Rapado-Castro M; Parellada M; Moreno C; Arango C
    Eur Neuropsychopharmacol; 2011 Aug; 21(8):621-45. PubMed ID: 20702068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication.
    Vedal TSJ; Steen NE; Birkeland KI; Dieset I; Reponen EJ; Laskemoen JF; Rødevand L; Melle I; Andreassen OA; Molden E; Jönsson EG
    J Psychiatr Res; 2018 Nov; 106():74-81. PubMed ID: 30292780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder.
    Demmo C; Lagerberg TV; Aminoff SR; Hellvin T; Kvitland LR; Simonsen C; Andreassen OA; Melle I; Ueland T
    Bipolar Disord; 2016 Mar; 18(2):136-47. PubMed ID: 26990158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opposite relationships between cannabis use and neurocognitive functioning in bipolar disorder and schizophrenia.
    Ringen PA; Vaskinn A; Sundet K; Engh JA; Jónsdóttir H; Simonsen C; Friis S; Opjordsmoen S; Melle I; Andreassen OA
    Psychol Med; 2010 Aug; 40(8):1337-47. PubMed ID: 19891810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of childhood trauma on working memory in affective and non-affective psychotic disorders.
    Quidé Y; O'Reilly N; Rowland JE; Carr VJ; Elzinga BM; Green MJ
    Brain Imaging Behav; 2017 Jun; 11(3):722-735. PubMed ID: 27090803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two-year follow-up of treated adolescents with early-onset bipolar disorder: Changes in neurocognition.
    Lera-Miguel S; Andrés-Perpiñá S; Fatjó-Vilas M; Fañanás L; Lázaro L
    J Affect Disord; 2015 Feb; 172():48-54. PubMed ID: 25451395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of second-generation antipsychotics in bipolar youth: comparison with other psychotic and nonpsychotic diagnoses.
    Moreno C; Merchán-Naranjo J; Alvarez M; Baeza I; Alda JA; Martínez-Cantarero C; Parellada M; Sánchez B; de la Serna E; Giráldez M; Arango C
    Bipolar Disord; 2010 Mar; 12(2):172-84. PubMed ID: 20402710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum testosterone levels are related to cognitive function in men with schizophrenia.
    Moore L; Kyaw M; Vercammen A; Lenroot R; Kulkarni J; Curtis J; O'Donnell M; Carr VJ; Shannon Weickert C; Weickert TW
    Psychoneuroendocrinology; 2013 Sep; 38(9):1717-28. PubMed ID: 23490072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex Differences in Verbal Memory Predict Functioning Through Negative Symptoms in Early Psychosis.
    Buck G; Lavigne KM; Makowski C; Joober R; Malla A; Lepage M
    Schizophr Bull; 2020 Dec; 46(6):1587-1595. PubMed ID: 32307536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum level of venlafaxine is associated with better memory in psychotic disorders.
    Steen NE; Aas M; Simonsen C; Dieset I; Tesli M; Nerhus M; Gardsjord E; Mørch R; Agartz I; Melle I; Vaskinn A; Spigset O; Andreassen OA
    Schizophr Res; 2015 Dec; 169(1-3):386-392. PubMed ID: 26516101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of arrest in persons with schizophrenia and bipolar disorder in a Florida Medicaid program: the role of atypical antipsychotics, conventional neuroleptics, and routine outpatient behavioral health services.
    Van Dorn RA; Andel R; Boaz TL; Desmarais SL; Chandler K; Becker MA; Howe A
    J Clin Psychiatry; 2011 Apr; 72(4):502-8. PubMed ID: 21527125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis.
    Barbero JD; Gutiérrez-Zotes A; Montalvo I; Creus M; Cabezas Á; Solé M; Algora MJ; Garcia-Parés G; Vilella E; Labad J
    Schizophr Res; 2015 Aug; 166(1-3):37-42. PubMed ID: 25982813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unblinded comparison of the clinical and cognitive effects of switching from first-generation antipsychotics to aripiprazole, perospirone or olanzapine in patients with chronic schizophrenia.
    Suzuki H; Gen K; Inoue Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jan; 35(1):161-8. PubMed ID: 21047544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment of executive function as a core symptom of schizophrenia.
    Wobrock T; Ecker UK; Scherk H; Schneider-Axmann T; Falkai P; Gruber O
    World J Biol Psychiatry; 2009; 10(4 Pt 2):442-51. PubMed ID: 18609418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.